Biomerica, Inc.

NasdaqCM:BMRA 株式レポート

時価総額：US$8.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Biomerica マネジメント

マネジメント 基準チェック /44

Biomerica'sの CEO はZack Iraniで、 Apr1997年に任命され、 の在任期間は 27.17年です。 の年間総報酬は$ 141.25Kで、 100%給与と0%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の6.07%を直接所有しており、その価値は$ 602.13K 。経営陣と取締役会の平均在任期間はそれぞれ2.7年と6.2年です。

主要情報

Zack Irani

最高経営責任者

US$141.3k

報酬総額

CEO給与比率100.0%
CEO在任期間27.2yrs
CEOの所有権6.1%
経営陣の平均在職期間2.7yrs
取締役会の平均在任期間6.2yrs

経営陣の近況

Recent updates

Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?

Dec 20
Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation

Aug 31
Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation

We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate

Mar 04
We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate

Amazon starts selling Biomerica's Aware Breast Self Exam device, EZ Detect test

Sep 29

Biomerica: One To Watch Closely For The Future, But From The Sidelines For Now

Sep 09

Biomerica reports FY results

Aug 29

Biomerica stock jumps after Walmart to begin selling co's Aware Breast Self Exam device

Jul 14

Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable

Dec 03
Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable

Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans

Dec 02
Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans

Is Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022

Sep 15

Biomerica (BMRA) Investor Presentation - Slideshow

Jun 14

Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Jun 13
Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook

Apr 04
Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook

Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?

Mar 08
Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?

Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Feb 10
Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders

Jan 15
The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders

Biomerica soars as its COVID-19 antigen test wins European nod

Jan 12

When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?

Dec 20
When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?

Biomerica clinical trial for IBS nears enrollment completion

Dec 09

How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?

Nov 23
How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?

CEO報酬分析

Biomerica の収益と比較して、Zack Irani の報酬はどのように変化したか？
日付総報酬給与会社業績
Feb 29 2024n/an/a

-US$6m

Nov 30 2023n/an/a

-US$6m

Aug 31 2023n/an/a

-US$6m

May 31 2023US$141kUS$141k

-US$7m

Feb 28 2023n/an/a

-US$7m

Nov 30 2022n/an/a

-US$6m

Aug 31 2022n/an/a

-US$5m

May 31 2022US$491kUS$135k

-US$5m

Feb 28 2022n/an/a

-US$4m

Nov 30 2021n/an/a

-US$7m

Aug 31 2021n/an/a

-US$7m

May 31 2021US$488kUS$137k

-US$7m

Feb 28 2021n/an/a

-US$6m

Nov 30 2020n/an/a

-US$5m

Aug 31 2020n/an/a

-US$4m

May 31 2020US$330kUS$137k

-US$2m

Feb 29 2020n/an/a

-US$3m

Nov 30 2019n/an/a

-US$2m

Aug 31 2019n/an/a

-US$2m

May 31 2019US$329kUS$137k

-US$2m

Feb 28 2019n/an/a

-US$2m

Nov 30 2018n/an/a

-US$2m

Aug 31 2018n/an/a

-US$2m

May 31 2018US$295kUS$137k

-US$1m

報酬と市場: Zackの 総報酬 ($USD 141.25K ) は、 US市場 ($USD 673.68K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Zackの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Zack Irani (58 yo)

27.2yrs

在職期間

US$141,250

報酬

Mr. Zackary S. Irani, also known as Zack, has been Chief Executive Officer of Biomerica Inc. since April 29, 1997 and is its Director and served as its President. He was Chairman of the Board at Biomerica...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Zackary Irani
CEO & Director27.2yrsUS$141.25k6.07%
$ 542.5k
Allen Barbieri
Executive Vice-Chairman of the Board & Corporate Secretary24.7yrsUS$126.25k0.55%
$ 49.6k
Gary Lu
Principal Accounting Officer & CFO1.3yrsUS$400.10kデータなし
Lucy Liu
Director of Manufacturing & Technical Operationsno dataデータなしデータなし
Robert Carlson
Chief Commercial Officer1.8yrsデータなしデータなし

2.7yrs

平均在職期間

58yo

平均年齢

経験豊富な経営陣: BMRAの経営陣は 経験豊富 であると考えられます ( 2.7年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Zackary Irani
CEO & Directorno dataUS$141.25k6.07%
$ 542.5k
Allen Barbieri
Executive Vice-Chairman of the Board & Corporate Secretary24.7yrsUS$126.25k0.55%
$ 49.6k
Edward Barnholt
Chairman of Strategic Advisory Board7.9yrsデータなしデータなし
Harry Leider
Member of Strategic Advisory Board6.2yrsデータなしデータなし
Douglas Drossman
Member of the Scientific Advisory Boardno dataデータなしデータなし
Jane Emerson
Independent Director17.2yrsUS$140.27k0.42%
$ 37.7k
Anthony Lembo
Member of Scientific Advisory Board7.9yrsデータなしデータなし
David Moatazedi
Independent Director1.5yrsUS$114.02kデータなし
John Kenny
Independent Chairman of the Boardless than a yearUS$87.77kデータなし
Catherine Coste
Independent Director3.8yrsUS$147.77k0.26%
$ 23.3k
Brooks Cash
Chairman of Colorectal Screening Scientific Advisory Board2.6yrsデータなしデータなし
William Whitehead
Member of the Scientific Advisory Boardno dataデータなしデータなし

6.2yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: BMRAの 取締役会 は 経験豊富 であると考えられます ( 6.2年の平均在任期間)。